In patients with extensive-stage small cell lung cancer, adding tarlatamab to durvalumab maintenance therapy significantly ...
Nivolumab-ipilimumab prolongs OS compared to nivolumab alone or chemo in MSI-H or dMMR, unresectable or metastatic colorectal ...
The intismeran/pembrolizumab combination significantly improved relapse-free and distant metastasis-free survival in advanced ...
In patients with muscle-invasive bladder cancer (MIBC), treatment with neoadjuvant durvalumab and enfortumab vedotin, with or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results